BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND PR, PGR, progesterone receptor AND Prognosis
41 results:

  • 1. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
    Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
    [No Abstract]    [Full Text] [Related]  

  • 2. Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
    Yang YH; Ansel S; Meerveld-Eggink A; Jackson-Spence F; Rallis K; Brian P; Choy J; Sng C; Adeniran P; Amin J; Galope S; Anderson N; Bex A; Powles T; Venugopal B; Szabados B
    Clin Genitourin Cancer; 2023 Aug; 21(4):e242-e251. PubMed ID: 36922286
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Usefulness of Immunostaining Scoring for Predicting Response to Single-Agent Nivolumab in Patients with Metastatic Renal Cell Carcinoma].
    Wakamiya T; Kubo T; Yamashita S; Kohjimoto Y; Torigoe T; Hara I
    Hinyokika Kiyo; 2022 Oct; 68(10):311-315. PubMed ID: 36329378
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma.
    Zhou L; Liu Y; Mo J; Cui C; Chi Z; Si L; Kong Y; Yan X; Li S; Wu X; Li J; Xu H; Cao D; Guo J; Sheng X
    Urol Oncol; 2022 Aug; 40(8):385.e1-385.e8. PubMed ID: 35773144
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A pre-operative prognostic model predicting all cause and cause specific mortality for women presenting with invasive breast cancer.
    Wang H; Donnan P; Macaskill EJ; Jordan L; Thompson A; Evans A
    Breast; 2022 Feb; 61():11-21. PubMed ID: 34891035
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
    Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
    Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The metabolic syndrome and its components are differentially associated with chronic diseases in a high-risk population of 350 000 adults: A cross-sectional study.
    Rayyan Assi H; Ziv A; Dankner R
    Diabetes Metab Res Rev; 2019 May; 35(4):e3121. PubMed ID: 30600581
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combined assessment of low pgrMC1/positive ATP1A1 levels has enhanced prognostic value for renal cell carcinoma.
    He Y; Zhang P; Zhang D; Xia Z; Wang X; Deng S; Li H; Zhu H; Xu N; Liang S
    Oncol Rep; 2018 Sep; 40(3):1467-1476. PubMed ID: 30015972
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer].
    Monneur A; Gonçalves A; Bertucci F
    Bull Cancer; 2018 Mar; 105(3):263-274. PubMed ID: 29455872
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characteristics and prognosis of breast cancer after liver or kidney transplantation.
    Jeong IJ; Lee SG; Kim YH; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2018 Jan; 167(1):101-106. PubMed ID: 28914398
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
    Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
    Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma.
    Liu L; Xiong Y; Xi W; Wang J; Qu Y; Lin Z; Chen X; Yao J; Xu J; Guo J
    Oncotarget; 2017 Feb; 8(9):14995-15003. PubMed ID: 28122358
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center.
    Afshar M; Pascoe J; Whitmarsh S; James N; Porfiri E
    Drug Des Devel Ther; 2015; 9():13-9. PubMed ID: 25552898
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients.
    Yang YF; Liao YY; Yang M; Peng NF; Xie SR; Xie YF
    Med Oncol; 2014 Oct; 31(10):214. PubMed ID: 25216864
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer].
    Maráz A; Bodrogi I; Csejtei A; Dank M; Géczi L; Küronya Z; Mangel L; Petrányi A; Szûcs M; Bodoky G
    Magy Onkol; 2013 Sep; 57(3):173-6. PubMed ID: 24107823
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sunitinib in metastatic renal cell carcimoma: a single-center experience.
    Krishna VM; Noronha V; Prabhash K; Joshi A; Patil V; Bhosale B; Ravi T; Menon H; Gupta S; Banavali SD; Bakshi G; Tangaonkar HB
    Indian J Cancer; 2013; 50(3):268-73. PubMed ID: 24061470
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Roles of trichorhinophalangeal syndrome-1 gene in normal breast development and breast cancer].
    Bao Y; Zhong ZX; Cui G; Guo L; Wang ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):121-4. PubMed ID: 23469802
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.
    Stroup SP; Raheem OA; Palazzi KL; Liss MA; Mehrazin R; Kopp RP; Patel N; Cohen SA; Park SK; Patterson AL; Kane CJ; Millard F; Derweesh IH
    Urology; 2013 Apr; 81(4):805-11. PubMed ID: 23414694
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A 13-year-old female with Xp11.2 translocation renal cell carcinoma; the first case diagnosed at Siriraj Hospital.
    Hanamornroongruang S; Treetipsatit J; Pongtanakul B; Seangchai N
    J Med Assoc Thai; 2012 Jul; 95(7):964-8. PubMed ID: 22919994
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.